As weeks of effort culminate in one night, here’s how the day of the show looked like — down to the minute. As a sophomore ...
Top: SEAMOUR, the robotic sea lion. Bottom: Its digital twin. A Drexel Engineering team has developed a highly accurate numerical model that predicts how their bio-robotic sea lion swims and maneuvers ...
Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting Orca ...
Q32 Bio on Monday sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics Inc. (NASDAQ: AKBA). ADX-097, the lead product candidate from Q32 Bio’s tissue-targeted complement inhibitor ...
Researchers based in Sweden have developed a metabolism-based model of mammalian cell types commonly used in antibody production. The team, led by Veronique Chotteau, PhD, a professor at KTH Royal ...
-- Cash and cash equivalents of $49.0 million as of September 30, 2025 expected to provide financial runway into 2027 -- WALTHAM, Mass., Nov. 13, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Gossamer Bio Inc. (GOSS) on Wednesday reported a loss of $48.2 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results